脂质体包裹的阿米卡星延长间隔治疗在实验性鸟分枝杆菌感染中的原理及疗效
Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.
作者信息
Leitzke S, Bucke W, Borner K, Müller R, Hahn H, Ehlers S
机构信息
Department of Infectious Diseases, Benjamin Franklin University Clinic, Free University of Berlin, Germany.
出版信息
Antimicrob Agents Chemother. 1998 Feb;42(2):459-61. doi: 10.1128/AAC.42.2.459.
Abstract
The potential of liposome-encapsulated antibiotics for prolonging drug application intervals was investigated by using a murine model of chronic lethal Mycobacterium avium infection. Liposomal encapsulation of amikacin, but not of ciprofloxacin, resulted in high and sustained drug levels in infected tissues, exceeding the minimal inhibitory concentration for M. avium for at least 28 days. As a consequence, once-weekly and even once-monthly treatments with liposomal amikacin significantly reduced bacterial replication in infected tissues and extended the survival time of infected mice.
摘要
通过使用慢性致死性鸟分枝杆菌感染的小鼠模型，研究了脂质体包裹抗生素延长药物应用间隔的潜力。阿米卡星脂质体包裹而非环丙沙星脂质体包裹，导致感染组织中药物水平高且持续，超过鸟分枝杆菌的最低抑菌浓度至少28天。因此，每周一次甚至每月一次用脂质体阿米卡星治疗可显著减少感染组织中的细菌复制，并延长感染小鼠的存活时间。
相似文献
1
Rationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.脂质体包裹的阿米卡星延长间隔治疗在实验性鸟分枝杆菌感染中的原理及疗效
Antimicrob Agents Chemother. 1998 Feb;42(2):459-61. doi: 10.1128/AAC.42.2.459.
2
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.脂质体包裹的阿米卡星对米色小鼠鸟分枝杆菌-胞内分枝杆菌复合感染的增强作用。
Antimicrob Agents Chemother. 1988 Sep;32(9):1404-11. doi: 10.1128/AAC.32.9.1404.
3
Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.脂质体阿米卡星用于在临床相关实验环境中治疗鸟分枝杆菌感染。
Zentralbl Bakteriol. 1996 Jul;284(2-3):218-31. doi: 10.1016/s0934-8840(96)80097-1.
4
Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.靶向药物递送可提高小鼠播散性鸟分枝杆菌感染的疗效并缩短治疗时间。
J Antimicrob Chemother. 2007 Nov;60(5):1064-73. doi: 10.1093/jac/dkm341. Epub 2007 Sep 10.
5
Liposomal amikacin: improved treatment of Mycobacterium avium complex infection in the beige mouse model.脂质体阿米卡星：在米色小鼠模型中改善鸟分枝杆菌复合群感染的治疗
J Antimicrob Chemother. 1996 Nov;38(5):819-28. doi: 10.1093/jac/38.5.819.
6
Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.脂质体包裹抗生素治疗细胞内鸟分枝杆菌感染的制剂与疗效
Antimicrob Agents Chemother. 1995 Sep;39(9):2104-11. doi: 10.1128/AAC.39.9.2104.
7
Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.用脂质体包裹的氨基糖苷类药物治疗米色小鼠播散性鸟分枝杆菌复合群感染
J Infect Dis. 1990 Jun;161(6):1262-8. doi: 10.1093/infdis/161.6.1262.
8
Liposome-encapsulated-amikacin therapy of Mycobacterium avium complex infection in beige mice.脂质体包裹的阿米卡星治疗米色小鼠鸟分枝杆菌复合群感染
Antimicrob Agents Chemother. 1989 Aug;33(8):1179-83. doi: 10.1128/AAC.33.8.1179.
9
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Complex (CONVERT). A Prospective, Open-Label, Randomized Study.卷曲霉素脂质体吸入混悬液治疗复杂（CONVERT）引起的治疗抵抗性肺病。一项前瞻性、开放标签、随机研究。
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569. doi: 10.1164/rccm.201807-1318OC.
10
Comparative activities of amikacin against Mycobacterium avium complex in nude and beige mice.丁胺卡那霉素对裸鼠和米色小鼠体内鸟分枝杆菌复合群的比较活性
Antimicrob Agents Chemother. 1997 May;41(5):1168-9. doi: 10.1128/AAC.41.5.1168.
引用本文的文献
1
Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections.用于治疗分枝杆菌感染的脂质体包封抗生素
Antibiotics (Basel). 2025 Jul 20;14(7):728. doi: 10.3390/antibiotics14070728.
2
Targeting Intracellular Mycobacteria Using Nanosized Niosomes Loaded with Antibacterial Agents.使用负载抗菌剂的纳米尺寸非离子表面活性剂囊泡靶向细胞内分枝杆菌。
Nanomaterials (Basel). 2021 Aug 1;11(8):1984. doi: 10.3390/nano11081984.
3
Polyurethane-functionalized starch nanocrystals as anti-tuberculosis drug carrier.聚氨酯功能化淀粉纳米晶作为抗结核药物载体。
Sci Rep. 2021 Apr 15;11(1):8331. doi: 10.1038/s41598-021-86767-1.
4
Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control.纳米药物作为抗结核药物的药物递送载体：从发病机制到感染控制。
Curr Drug Deliv. 2019;16(5):400-429. doi: 10.2174/1567201816666190201144815.
5
Amikacin: Uses, Resistance, and Prospects for Inhibition.阿米卡星：用途、耐药性和抑制前景。
Molecules. 2017 Dec 19;22(12):2267. doi: 10.3390/molecules22122267.
6
Nanotechnology-Based Approach in Tuberculosis Treatment.基于纳米技术的结核病治疗方法。
Tuberc Res Treat. 2017;2017:4920209. doi: 10.1155/2017/4920209. Epub 2017 Jan 22.
7
Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases.纳米技术与肺部递药：克服传染病中的耐药性。
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1816-27. doi: 10.1016/j.addr.2013.07.020. Epub 2013 Aug 7.
8
Targeted delivery of amikacin into granuloma.将阿米卡星靶向递送至肉芽肿中。
Am J Respir Crit Care Med. 2010 Dec 15;182(12):1546-53. doi: 10.1164/rccm.200912-1888OC. Epub 2010 Aug 6.
9
Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.聚乙二醇包被脂质体包裹的环丙沙星：在大鼠急性或慢性铜绿假单胞菌感染模型中的疗效
Antimicrob Agents Chemother. 2002 Aug;46(8):2575-81. doi: 10.1128/AAC.46.8.2575-2581.2002.
10
Gamma interferon is essential for clearing Mycobacterium genavense infection.γ干扰素对于清除日内瓦分枝杆菌感染至关重要。
Infect Immun. 2000 Jun;68(6):3720-3. doi: 10.1128/IAI.68.6.3720-3723.2000.
本文引用的文献
1
Disseminated Mycobacterium avium complex disease in the Swiss HIV Cohort Study: increasing incidence, unchanged prognosis.瑞士HIV队列研究中的播散性鸟分枝杆菌复合群疾病：发病率上升，预后未变。
AIDS. 1997 Jul 15;11(9):1165-71. doi: 10.1097/00002030-199709000-00013.
2
Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells.小鼠鸟分枝杆菌感染中肉芽肿形成的机制：CD4 + T细胞的作用
Int Immunol. 1996 Aug;8(8):1299-310. doi: 10.1093/intimm/8.8.1299.
3
Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.脂质体阿米卡星用于在临床相关实验环境中治疗鸟分枝杆菌感染。
Zentralbl Bakteriol. 1996 Jul;284(2-3):218-31. doi: 10.1016/s0934-8840(96)80097-1.
4
Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection.脂质体包裹抗生素治疗细胞内鸟分枝杆菌感染的制剂与疗效
Antimicrob Agents Chemother. 1995 Sep;39(9):2104-11. doi: 10.1128/AAC.39.9.2104.
5
The Mycobacterium avium complex.鸟分枝杆菌复合体
Clin Microbiol Rev. 1993 Jul;6(3):266-310. doi: 10.1128/CMR.6.3.266.
6
Liposomes in the treatment of infections.脂质体在感染治疗中的应用。
J Drug Target. 1994;2(5):363-71. doi: 10.3109/10611869408996811.
7
Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.荧光偏振免疫测定法。I. 监测血清和血浆中的氨基糖苷类抗生素。
Clin Chem. 1981 Jul;27(7):1190-7.
8
Mycobacterium avium complex infection.鸟分枝杆菌复合群感染
J Infect Dis. 1988 May;157(5):863-7. doi: 10.1093/infdis/157.5.863.
9
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.脂质体包裹的阿米卡星对米色小鼠鸟分枝杆菌-胞内分枝杆菌复合感染的增强作用。
Antimicrob Agents Chemother. 1988 Sep;32(9):1404-11. doi: 10.1128/AAC.32.9.1404.
10
Liquid chromatographic determination of ciprofloxacin and some metabolites in human body fluids.人体体液中环丙沙星及其某些代谢物的液相色谱测定法。
J Clin Chem Clin Biochem. 1986 May;24(5):325-31. doi: 10.1515/cclm.1986.24.5.325.
Zotero 插件